Shen Lu
About Shen Lu
Shen Lu is a Principal Associate Scientist at ElevateBio, where he manages the production of research-grade lentiviral vectors and develops viral-engineered cell lines. He holds a Master of Science in Biochemistry and Molecular Biology from Georgetown University and has previous experience as a Senior Research Associate at Codex BioSolutions.
Work at ElevateBio
Shen Lu serves as a Principal Associate Scientist at ElevateBio, a position held since 2021. In this role, Lu manages and produces research-grade lentiviral vectors for early construct assessment. Additionally, Lu develops and optimizes immunoassays and in vitro cell-based assays to support various research efforts. Lu also produces viral-engineered cell lines for research and development assays, contributing to the advancement of biotechnological research at the company.
Education and Expertise
Shen Lu has a strong academic background in the life sciences. Lu earned a Master of Science (M.S.) in Biochemistry and Molecular Biology from Georgetown University, studying from 2015 to 2016. Prior to this, Lu completed a Bachelor of Science (B.S.) in Biotechnology at Capital Normal University from 2009 to 2013. Additionally, Lu participated in an exchange program at the University of Tübingen, focusing on the Program of Neuron Science from 2012 to 2013.
Background
Before joining ElevateBio, Shen Lu worked as a Senior Research Associate at Codex BioSolutions from 2016 to 2021. During this five-year tenure in Gaithersburg, MD, Lu gained valuable experience in research and development within the biotechnology sector. This experience laid the foundation for Lu's current role, where advanced skills in molecular biology and biochemistry are applied.
Achievements
At ElevateBio, Shen Lu has made significant contributions to the production of research-grade lentiviral vectors and the development of various assays. These efforts support critical research initiatives and enhance the capabilities of the organization in the biotechnology field. Lu's work in producing viral-engineered cell lines further demonstrates expertise in the area of research and development.